(Depakote, Depakote Sprinkles, Depakote ER). PEFC Approved: February 2024 20% and an increase of dose may be required. ○ Therapeutic ranges for
(Depakote, Depakote Sprinkles, Depakote ER). PEFC Approved: February 2024 Therapeutic ranges for the lab used should be listed on the report.
Reference Range Depakote The therapeutic range for valproic acid (total) is µg/mL. The toxic level is greater than 150 µg/mL. The therapeutic range for
(Depakote, Depakote Sprinkles, Depakote ER). PEFC Approved: February 2024 Therapeutic ranges for the lab used should be listed on the report.
therapeutic range, infant exposure was 0.9% to 2.3% of maternal levels. 1 Mean dose of Depakote was 1,087 mg/day. 2 Dose of Depakote was 500 or
Reference Range Depakote The therapeutic range for valproic acid (total) is µg/mL. The toxic level is greater than 150 µg/mL. The therapeutic range for
bipolar disorder. Therapeutic range: 3–14 mcg/mL (or titrated to therapeutic effect). Valproic acid, divalproex sodium (Depakote, Depakote ER)
(Depakote, Depakote Sprinkles, Depakote ER). PEFC Approved: February 2024 Therapeutic ranges for the lab used should be listed on the report.
Reference Range Depakote The therapeutic range for valproic acid (total) is µg/mL. The toxic level is greater than 150 µg/mL. The therapeutic range for
Comments